SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Algernon Pharmaceuticals Inc. (AGNPF) , 前瞻盈利收益率 2,000.00%.
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
- 前瞻市盈率 0.1
SharesGrow 综合评分： 21/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — AGNPF
估值倍数
P/E (TTM)0.0
前瞻 P/E0.1
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.06
前瞻 EPS（预估）$0.69
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield2,000.00%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-9.75 |
$0.00 |
$-6.88M |
- |
| 2017 |
$-1.84 |
$0.00 |
$-1.89M |
- |
| 2018 |
$-0.83 |
$0.00 |
$-938K |
- |
| 2019 |
$-1.06 |
$0.00 |
$-1.9M |
- |
| 2020 |
$-2.42 |
$0.00 |
$-8.54M |
- |
| 2021 |
$-1.24 |
$0.00 |
$-7.73M |
- |
| 2022 |
$-0.87 |
$0.00 |
$-6.05M |
- |
| 2023 |
$-0.45 |
$0.00 |
$-6.78M |
- |
| 2024 |
$-0.03 |
$0.00 |
$-503K |
- |
| 2025 |
$-0.06 |
$0.00 |
$-1.72M |
- |
